SCHEMBL22715212

SCHEMBL22715212

Cc1nc(N)c(N)c(=O)[nH]1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PARP1 P09874 10/20 0.43
TNKS2 Q9H2K2 1/20 0.39
MAPK1 P28482 1/20 0.38
GAA P10253 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 1/20 0.36
USP2 O75604 1/20 0.36
GLA P06280 1/20 0.36
RAB9A P51151 1/20 0.36
PARP15 Q460N3 1/20 0.35
PARP3 Q9Y6F1 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3167024 0.77 ALDH1A1 (0.50) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL1271646 0.75 CDK1 (0.56) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL12474436 0.73 CDK1 (0.54) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL4321719 0.71 KDM4C (0.45) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL5551189 0.71 HTT (0.47) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL11683196 0.71 ALDH1A1 (0.42) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL11683430 0.71 ALDH1A1 (0.42) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL18362200 0.70 ALDH1A1 (0.52) ALDH1A1L3MBTL1MAPTHPGDSMN1; SMN2
SCHEMBL22787117 0.69 ALDH1A1 (0.55) ALDH1A1L3MBTL1PARP1TNKS2MAPK1
SCHEMBL22931024 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617789-B2 Small molecular inhibitors of NF-κb inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2026-05-05 US disclosed
EP-4467199-A2 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2024-11-27 EP disclosed
CN-118908957-A Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-11-08 CN disclosed
EP-3976597-B1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2024-08-28 EP disclosed
CN-114222737-B Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-07-26 CN disclosed
US-20240199605-A1 SMALL MOLECULAR INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2024-06-20 US disclosed
US-11827634-B2 Small molecule inhibitors of NF-kB inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2023-11-28 US disclosed
US-20230080834-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-03-16 US disclosed
EP-3976597-A1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE Janssen Pharmaceutica NV (BE) 2022-04-06 EP disclosed
CN-114222737-A Small molecule inhibitor of NF-kB induced kinase 詹森药业有限公司 2022-03-22 CN disclosed
US-11254673-B2 Small molecule inhibitors of NF-κB inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2022-02-22 US disclosed
US-20210300918-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2021-09-30 US disclosed
WO-2020239999-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2020-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300918-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE NFKBIA, IKBKB, NFRKB ALDH1A1 4109/4885L3MBTL1 1563/4885MAPT 1462/4885
US-20230080834-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE NFKBIA, IKBKB, NFRKB ALDH1A1 4109/4885L3MBTL1 1563/4885MAPT 1462/4885
US-11827634-B2 Small molecule inhibitors of NF-kB inducing kinase NFKBIA, IKBKB, NFRKB ALDH1A1 4109/4885L3MBTL1 1563/4885MAPT 1462/4885
US-11254673-B2 Small molecule inhibitors of NF-κB inducing kinase NFKBIA, IKBKB, CHUK ALDH1A1 3934/4885L3MBTL1 1803/4885MAPT 1688/4885
US-12617789-B2 Small molecular inhibitors of NF-κb inducing kinase IRAK3, IKBKB, IKBKG ALDH1A1 3824/4885L3MBTL1 1946/4885MAPT 4109/4885
US-20240199605-A1 SMALL MOLECULAR INHIBITORS OF NF-kB INDUCING KINASE NFKBIA, IKBKB, IKBKE ALDH1A1 4012/4885L3MBTL1 1682/4885MAPT 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.